MABB - Biomaterial & Bioengineering is an innovative brand that specializes in the generation of medical technology projects. With our state-of-the-art Biomaterials Innovation Center, we transform modern ceramic biomaterials into implantable medical devices. By leveraging our expertise in design and manufacturing, we turn your ideas into high-quality, reliable, and cost-effective ceramic implant systems.

Our revolutionary Injection Molding of Ceramics (CIM) technology allows us to produce high-volume precision parts at a low cost per unit. This groundbreaking process enables us to create pieces with geometries similar to those available in plastic, while harnessing the strong and inert properties of advanced nanoceramic materials. At MABB, we ensure quality through our ISO 9001 certification, resulting in maximum repeatability, minimal rejects, and statistical process control.

We generate medical products for international markets, including FDA, CE, ANMAT, ANVISA, and more, through our proprietary system and strategic alliances. Our team of engineers provides expert advice on designing economically viable and geometrically suitable parts for the CIM process, optimizing productivity and minimizing costs. CIM offers greater design freedom compared to other production methods, leading to enhanced manufacturing stability, product quality, and market competitiveness.

With our cutting-edge Injection Molding of Ceramics technology, MABB offers a sustainable production solution that eliminates intermediate machining and reduces waste. Unlike traditional dry pressing methods, CIM allows for the production of complex shapes with desired tolerances and surface finishes, including reentrant angles, blind holes, internal and external threads, intricate surface profiles, perpendicular holes, and cavities, all in a single step. Experience the benefits of our strategic alliances and join us in revolutionizing the field of biomaterials and bioengineering